Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Heparin-induced thrombocytopenia: recommendations for optimal use of recombinant hirudinN Lubenow, A GreinacherVox Sanguinis|February 19, 2016
Predonation finger lancet punctures: a potential risk factor for interdonor pathogen transmission in the blood donor clinicA Greinacher, N LubenowAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopeniaN Lubenow, A GreinacherCirculation|March 14, 2001
Recombinant hirudin in clinical practice: focus on lepirudinA Greinacher, N LubenowHamostaseologie|September 7, 2002
[Hirudins in the treatment of heparin-induced thrombocytopenia and in thrombosis prophylaxis]N Lubenow, A GreinacherCirculation|October 22, 2003
Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopeniaA Greinacher, N Lubenow, P EichlerReviews in Clinical and Experimental Hematology|November 13, 2001
Drug-induced and drug-dependent immune thrombocytopeniasA Greinacher, P Eichler, N Lubenow, et al.Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3N Lubenow, P Eichler, T Lietz, et al.Deutsche Medizinische Wochenschrift (1946)|October 17, 2003
[Informed consent on heparin-induced thrombocytopenia during thrombosis prophylaxis. A pilot study including 460 patients]P Hinz, N Lubenow, A Ekkernkamp, et al.Der Unfallchirurg|September 17, 2002
[Current recommendations for diagnosis and therapy of heparin-induced thrombocytopenia]P Hinz, N Lubenow, A Eckernkamp, et al.Pageof 3